Targeting protein-protein interaction between MLL1 and reciprocal proteins for leukemia therapy

Epigenetics in human disease and prospects for epigenetic therapy

Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232 · see citing works

Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1

Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S.-E., Collins, F. S., Emmert‐Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., et al. (1997) · Science · doi:10.1126/science.276.5311.404 · Cited by 2,076 · see citing works

Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9

Krivtsov, A. V., Twomey, D., Feng, Z., Stubbs, M. C., Wang, Y., Faber, J., Levine, J. E., Wang, J., Hahn, W. C., Gilliland, D. G., et al. (2006) · Nature · doi:10.1038/nature04980 · Cited by 1,513 · see citing works

MLL translocations, histone modifications and leukaemia stem-cell development

Krivtsov, A., & Armstrong, S. (2007) · Nature Reviews. Cancer · doi:10.1038/nrc2253 · Cited by 1,294 · see citing works

Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark

Ruthenburg, A. J., Allis, C. D., & Wysocka, J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.12.014 · Cited by 1,147 · see citing works

WDR5 Associates with Histone H3 Methylated at K4 and Is Essential for H3 K4 Methylation and Vertebrate Development

Wysocka, J., Swigut, T., Milne, T. A., Dou, Y., Zhang, X., Burlingame, A. L., Roeder, R. G., Brivanlou, A. H., & Allis, C. D. (2005) · Cell · doi:10.1016/j.cell.2005.03.036 · Cited by 820 · see citing works

The Menin Tumor Suppressor Protein Is an Essential Oncogenic Cofactor for MLL-Associated Leukemogenesis

Yokoyama, A., Somervaille, T. C. P., Smith, K. S., Rozenblatt–Rosen, O., Meyerson, M. M., & Cleary, M. L. (2005) · Cell · doi:10.1016/j.cell.2005.09.025 · Cited by 698 · see citing works

Leukemia Proto-Oncoprotein MLL Forms a SET1-Like Histone Methyltransferase Complex with Menin To Regulate Hox Gene Expression

Yokoyama, A., Wang, Z., Wysocka, J., Sanyal, M., Aufiero, D. J., Kitabayashi, I., Herr, W., & Cleary, M. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5639-5649.2004 · Cited by 661 · see citing works

Menin Critically Links MLL Proteins with LEDGF on Cancer-Associated Target Genes

Yokoyama, A., & Cleary, M. L. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.003 · Cited by 550 · see citing works

DOT1L/KMT4 Recruitment and H3K79 Methylation Are Ubiquitously Coupled with Gene Transcription in Mammalian Cells

Steger, D. J., Lefterova, M. I., Ying, L., Stonestrom, A. J., Schupp, M., Zhuo, D. X., Vakoc, A. L., Kim, J., Chen, J., Lazar, M. A., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02076-07 · Cited by 499 · see citing works

Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia

Grembecka, J. E., He, S., Shi, A., Purohit, T., Muntean, A. G., Sorenson, R. J., Showalter, H. D., Murai, M. J., Belcher, A. M., Hartley, T., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.773 · Cited by 468 · see citing works

New insights to the MLL recombinome of acute leukemias

Meyer, C., Kowarz, E., Hofmann, J., Renneville, A., Zuna, J., Trka, J., Abdelali, R. B., Macintyre, E. A., Braekeleer, E. D., Braekeleer, M. D., et al. (2009) · Leukemia · doi:10.1038/leu.2009.33 · Cited by 407 · see citing works

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

Pui, C., Gaynon, P. S., Boyett, J. M., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08782-2 · Cited by 403 · see citing works

Biological and therapeutic aspects of infant leukemia

Biondi, A., Cimino, G. G., Pieters, R., et al. (2000) · Blood · doi:10.1182/blood.v96.1.24 · Cited by 403 · see citing works

Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors.

Jude, C. D., Climer, L. K., Xu, D.-Y., Artinger, E. L., Fisher, J., & Ernst, P. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.05.019 · Cited by 350 · see citing works

Pharmacologic inhibition of the menin-MLL interaction blocks progression of MLL leukemia in vivo

Borkin, D., He, S., Miao, H., Kempińska, K., Pollock, J., Chase, J., Purohit, T., Malik, B., Zhao, T., Wang, J.-Y., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.016 · Cited by 350 · see citing works

Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization

Zeisig, B. B., Milne, T., García-Cuéllar, M.-P., Schreiner, S., Martin, M.-E., Fuchs, U., Borkhardt, A., Chanda, S. K., Walker, J. R., Soden, R., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.617-628.2004 · Cited by 330 · see citing works

The same pocket in menin binds both MLL and JUND but has opposite effects on transcription

Huang, J., Gurung, B., Wan, B., Matkar, S. S., Veniaminova, N. A., Wan, K., Merchant, J. L., Hua, X., & Lei, M. (2012) · Nature · doi:10.1038/nature10806 · Cited by 310 · see citing works

Targeting MLL1 H3K4 Methyltransferase Activity in Mixed-Lineage Leukemia

Cao, F., Townsend, E. C., Karataş, H., Xu, J., Li, L., Lee, S. H. F., Liu, L., Chen, Y., Ouillette, P. D., Zhu, J., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.001 · Cited by 306 · see citing works

Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia

Grebien, F., Vedadi, M., Getlik, M., Giambruno, R., Grover, A., Avellino, R., Skucha, A., Vittori, S., Kuznetsova, E., Smil, D., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1859 · Cited by 284 · see citing works

Mll Has a Critical Role in Fetal and Adult Hematopoietic Stem Cell Self-Renewal

McMahon, K. A., Hiew, S., Hadjur, S., Veiga‐Fernandes, H., Menzel, U., Price, A. J., Kioussis, D., Williams, O., & Brady, H. J. M. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.07.002 · Cited by 274 · see citing works

The Human PAF1 Complex Acts in Chromatin Transcription Elongation Both Independently and Cooperatively with SII/TFIIS

Kim, J., Guermah, M., & Roeder, R. G. (2010) · Cell · doi:10.1016/j.cell.2009.12.050 · Cited by 273 · see citing works

MLL-AF9-Induced Leukemogenesis Requires Co-Expression of the Wild Type Mll Allele

Thiel, A. T., Blessington, P., Zou, T., Feather, D., Wu, X.-J., Yan, J.-Z., Zhang, H., Liu, Z.-G., Ernst, P., Koretzky, G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.034 · Cited by 249 · see citing works

Structural basis for activity regulation of MLL family methyltransferases

Li, Y., Han, J., Zhang, Y., Cao, F., Liu, Z., Li, S., Wu, J., Hu, C., Wang, Y., Jin, S., et al. (2016) · Nature · doi:10.1038/nature16952 · Cited by 244 · see citing works

Proteolytic Cleavage of MLL Generates a Complex of N- and C-Terminal Fragments That Confers Protein Stability and Subnuclear Localization

Hsieh, J. J.-D., Ernst, P., Erdjument‐Bromage, H., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.186-194.2003 · Cited by 235 · see citing works

The PAF Complex Synergizes with MLL Fusion Proteins at HOX Loci to Promote Leukemogenesis

Muntean, A. G., Tan, J., Sitwala, K. V., Huang, Y., Bronstein, J. C., Connelly, J. A., Basrur, V., Elenitoba‐Johnson, K. S. J., & Hess, J. L. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.04.012 · Cited by 232 · see citing works

Multiple Interactions Recruit MLL1 and MLL1 Fusion Proteins to the HOXA9 Locus in Leukemogenesis

Milne, T. A., Kim, J., Wang, G. G., Stadler, S. C., Basrur, V., Whitcomb, S. J., Wang, Z., Ruthenburg, A. J., Elenitoba‐Johnson, K. S. J., Roeder, R. G., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.011 · Cited by 231 · see citing works

Structural Basis for the Requirement of Additional Factors for MLL1 SET Domain Activity and Recognition of Epigenetic Marks

Southall, S. M., Wong, P. S., Odho, Z., Roe, S. M., & Wilson, J. R. (2009) · Molecular Cell · doi:10.1016/j.molcel.2008.12.029 · Cited by 231 · see citing works

Epigenetic targets in hematopoietic malignancies

Claus, R., & Lübbert, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206814 · Cited by 214 · see citing works

Erratum: Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia

Grebien, F., Vedadi, M., Getlik, M., Giambruno, R., Grover, A., Avellino, R., Skucha, A., Vittori, S., Kuznetsova, E., Smil, D. V., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio1015-815b · Cited by 206 · see citing works

High-Affinity, Small-Molecule Peptidomimetic Inhibitors of MLL1/WDR5 Protein–Protein Interaction

Karataş, H., Townsend, E. C., Cao, F., Chen, Y., Bernard, D., Liu, L., Lei, M., Dou, Y., & Wang, S. (2012) · Journal of the American Chemical Society · doi:10.1021/ja306028q · Cited by 205 · see citing works

Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemia

Shi, A., Murai, M. J., He, S., Lund, G., Hartley, T., Purohit, T., Reddy, G., Chruszcz, M., Grembecka, J. E., & Cierpicki, T. (2012) · Blood · doi:10.1182/blood-2012-05-429274 · Cited by 205 · see citing works

The Paf1 Complex Has Functions Independent of Actively Transcribing RNA Polymerase II

Mueller, C. L., Porter, S. E., Hoffman, M. G., et al. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00257-6 · Cited by 194 · see citing works

Structure of WDR5 Bound to Mixed Lineage Leukemia Protein-1 Peptide

Patel, A. B., Dharmarajan, V., & Cosgrove, M. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800164200 · Cited by 173 · see citing works

Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5

Senisterra, G. A., Wu, H. Y., Allali‐Hassani, A., Wasney, G. A., Baršytė-Lovejoy, D., Dombrovski, L., Dong, A., Nguyen, K. T., Smil, D. V., Bolshan, Y., et al. (2012) · Biochemical Journal · doi:10.1042/bj20121280 · Cited by 165 · see citing works

Clinical and laboratory characteristics of acute leukemia with the 4;11 translocation

Mirro, J., Kitchingman, G., Williams, D., et al. (1986) · Blood · doi:10.1182/blood.v67.3.689.689 · Cited by 135 · see citing works

Biochemical Reconstitution and Phylogenetic Comparison of Human SET1 Family Core Complexes Involved in Histone Methylation

Shinsky, S. A., Monteith, K. E., Viggiano, S. C., & Cosgrove, M. S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.627646 · Cited by 116 · see citing works

Epigenetic regulation in Parkinson’s disease

Labbé, C., Lorenzo‐Betancor, O., & Ross, O. A. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1590-9 · Cited by 115 · see citing works

Rational Design of Orthogonal Multipolar Interactions with Fluorine in Protein–Ligand Complexes

Pollock, J., Borkin, D., Lund, G., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00975 · Cited by 111 · see citing works

Epigenomics of leukemia: from mechanisms to therapeutic applications

Florean, C., Schnekenburger, M., Grandjenette, C., Dicato, M. A., & Diederich, M. F. (2011) · Epigenomics · doi:10.2217/epi.11.73 · Cited by 105 · see citing works

Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)–Mixed Lineage Leukemia (MLL) Protein–Protein Interaction

Karataş, H., Li, Y., Liu, L., Ji, J., Lee, S. H. F., Chen, Y., Yang, J., Huang, L., Bernard, D., Xu, J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01796 · Cited by 103 · see citing works

High-Affinity Small-Molecule Inhibitors of the Menin-Mixed Lineage Leukemia (MLL) Interaction Closely Mimic a Natural Protein–Protein Interaction

He, S., Senter, T. J., Pollock, J., Han, C., Upadhyay, S. K., Purohit, T., Gogliotti, R. D., Lindsley, C. W., Cierpicki, T., Stauffer, S. R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401868d · Cited by 99 · see citing works

Molecular Basis of the Mixed Lineage Leukemia-Menin Interaction

Grembecka, J. E., Belcher, A. M., Hartley, T., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.172783 · Cited by 96 · see citing works

Structure-Based Design of High-Affinity Macrocyclic Peptidomimetics to Block the Menin-Mixed Lineage Leukemia 1 (MLL1) Protein–Protein Interaction

Zhou, H., Liu, L., Huang, J., Bernard, D., Karataş, H., Navarro, A., Lei, M., & Wang, S. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3015298 · Cited by 94 · see citing works

Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1)

Getlik, M., Smil, D. V., Zepeda‐Velázquez, C., Bolshan, Y., Poda, G. I., Wu, H. Y., Dong, A., Kuznetsova, E., Marcellus, R. C., Senisterra, G. A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01630 · Cited by 94 · see citing works

Epigenetic drug discovery for Alzheimer’s disease

Cacabelos, R., & Torrellas, C. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.930124 · Cited by 86 · see citing works

Alterations of the CxxC domain preclude oncogenic activation of mixed-lineage leukemia 2

Bach, C., Mueller, D., Buhl, S., García-Cuéllar, M.-P., & Slany, R. K. (2008) · Oncogene · doi:10.1038/onc.2008.443 · Cited by 85 · see citing works

The der(11)-encoded MLL/AF-4 fusion transcript is consistently detected in t(4;11)(q21;q23)-containing acute lymphoblastic leukemia

Downing, J. R., Head, D., Raimondi, S., et al. (1994) · Blood · doi:10.1182/blood.v83.2.330.330 · Cited by 81 · see citing works

Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes

Alicea‐Velázquez, N. L., Shinsky, S. A., Loh, D. M., Lee, J., Skalnik, D. G., & Cosgrove, M. S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.752626 · Cited by 77 · see citing works

Analysis of the Binding of Mixed Lineage Leukemia 1 (MLL1) and Histone 3 Peptides to WD Repeat Domain 5 (WDR5) for the Design of Inhibitors of the MLL1−WDR5 Interaction

Karataş, H., Townsend, E. C., Bernard, D., Dou, Y., & Wang, S. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100139b · Cited by 75 · see citing works

Multiple cellular proteins interact with LEDGF/p75 through a conserved unstructured consensus motif

Tesina, P., Čermáková, K., Hořejší, M., Procházková, K., Fábry, M., Sharma, S., Christ, F., Demeulemeester, J., Debyser, Z., Rijck, J. D., et al. (2015) · Nature Communications · doi:10.1038/ncomms8968 · Cited by 74 · see citing works

Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction

Bolshan, Y., Getlik, M., Kuznetsova, E., Wasney, G. A., Hajian, T., Poda, G. I., Nguyen, K. T., Wu, H. Y., Dombrovski, L., Dong, A., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300467n · Cited by 74 · see citing works

Developmentally induced Mll1 loss reveals defects in postnatal haematopoiesis

Gan, T., Jude, C. D., Zaffuto, K. M., et al. (2010) · Leukemia · doi:10.1038/leu.2010.171 · Cited by 73 · see citing works

Mixed lineage leukemia: roles in human malignancies and potential therapy

Marschalek, R. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07608.x · Cited by 68 · see citing works

Complete exon structure of the ALL1 gene.

Rasio, D., Schichman, S. A., Negrini, M., et al. (1996) · PubMed · Cited by 67 · see citing works

Property Focused Structure-Based Optimization of Small Molecule Inhibitors of the Protein–Protein Interaction between Menin and Mixed Lineage Leukemia (MLL)

Borkin, D., Pollock, J., Kempińska, K., Purohit, T., Li, X., Wen, B., Zhao, T., Miao, H., Shukla, S., He, M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01305 · Cited by 61 · see citing works

Structure-based design and synthesis of small molecular inhibitors disturbing the interaction of MLL1-WDR5

Li, D., Chen, W., Xu, X., Jiang, F., Wang, L., Xie, Y.-Y., Zhang, X., Guo, X., You, Q., & Sun, H.-P. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.04.032 · Cited by 55 · see citing works

High-affinity small molecular blockers of mixed lineage leukemia 1 (MLL1)-WDR5 interaction inhibit MLL1 complex H3K4 methyltransferase activity

Li, D., Chen, W., Wang, Z., Xie, Y.-Y., Xu, X., Jiang, Z., Zhang, X., You, Q., & Guo, X. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.036 · Cited by 53 · see citing works

Validation and Structural Characterization of the LEDGF/p75–MLL Interface as a New Target for the Treatment of MLL-Dependent Leukemia

Čermáková, K., Těšina, P., Demeulemeester, J., Ashkar, S. E., Méreau, H., Schwaller, J., Řezáčová, P., Veverka, V., & Rijck, J. D. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3602 · Cited by 52 · see citing works

Impairing MLL-fusion gene-mediated transformation by dissecting critical interactions with the lens epithelium-derived growth factor (LEDGF/p75)

Méreau, H., Rijck, J. D., Čermáková, K., Kutz, A., Juge, S., Demeulemeester, J., Gijsbers, R., Christ, F., Debyser, Z., & Schwaller, J. (2013) · Leukemia · doi:10.1038/leu.2013.10 · Cited by 49 · see citing works

Epigenetic Changes in Neurodegenerative Diseases

Kwon, M. J., Kim, S., Han, M., & Lee, S. B. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0233 · Cited by 47 · see citing works

Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis

Ballabio, E., & Milne, T. A. (2012) · Cancers · doi:10.3390/cancers4030904 · Cited by 45 · see citing works

The same site on the integrase-binding domain of lens epithelium–derived growth factor is a therapeutic target for MLL leukemia and HIV

Murai, M. J., Pollock, J., He, S., Miao, H. Z., Purohit, T., Yokom, A. L., Hess, J. L., Muntean, A. G., Grembecka, J. E., & Cierpicki, T. (2014) · Blood · doi:10.1182/blood-2014-01-550079 · Cited by 41 · see citing works

Structure-based screening and optimization of cytisine derivatives as inhibitors of the menin–MLL interaction

Zhong, H.-J., Lee, B. R., Boyle, J. W., Wang, W., Ma, D.-L., Hong Chan, P. W., & Leung, C.-H. (2016) · Chemical Communications · doi:10.1039/c6cc01079b · Cited by 38 · see citing works

Molecular mechanisms of MLL-associated leukemia

Yokoyama, A. (2015) · International journal of hematology · doi:10.1007/s12185-015-1774-4 · Cited by 37 · see citing works

Structure-based design of ester compounds to inhibit MLL complex catalytic activity by targeting mixed lineage leukemia 1 (MLL1)–WDR5 interaction

Li, D., Wang, Z., Chen, W., Xie, Y.-Y., You, Q., & Guo, X. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.09.073 · Cited by 24 · see citing works

Discovery of two aminoglycoside antibiotics as inhibitors targeting the menin–mixed lineage leukaemia interface

Li, L., Zhou, R., Geng, H., Yue, L., Ye, F., Xie, Y., Liu, J.-Q., Kong, X., Jiang, H., Huang, J., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.055 · Cited by 23 · see citing works

Identification of novel small-molecule inhibitors targeting menin–MLL interaction, repurposing the antidiarrheal loperamide

Yue, L., Du, J., Ye, F., Chen, Z., Li, L., Lian, F., Zhang, B., Zhang, Y., Jiang, H., Chen, K., et al. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob01248e · Cited by 20 · see citing works

Dynamics of the Ternary Complex Formed by c-Myc Interactor JPO2, Transcriptional Co-activator LEDGF/p75, and Chromatin

Hendrix, J., van Heertum, B., Vanstreels, E., Daelemans, D., & Rijck, J. D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.525964 · Cited by 13 · see citing works

Progress towards small molecule menin-mixed lineage leukemia (MLL) interaction inhibitors with in vivo utility

Senter, T. J., Gogliotti, R. D., Han, C., Locuson, C. W., Morrison, R. D., Daniels, J. S., Cierpicki, T., Grembecka, J. E., Lindsley, C. W., & Stauffer, S. R. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.04.026 · Cited by 11 · see citing works

Design and synthesis of benzylpiperidine inhibitors targeting the menin–MLL1 interface

Ren, J., Xü, W., Tang, L., Su, M., Chen, D., Chen, Y.-L., Zang, Y., Li, J., Shen, J., Zhou, Y., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.07.074 · Cited by 9 · see citing works

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396 · see citing works

Architects meets Repairers: the interplay between homeobox genes and DNA repair

Feltes, B. C. (2019) · DNA Repair · doi:10.1016/j.dnarep.2018.10.007 · Cited by 15 · see citing works

Arginine Methylation of the PGC-1α C-Terminus Is Temperature-Dependent

Mendoza, M., Mendoza, M. R., Lubrino, T., Briski, S., Osuji, I., Cuala, J., Ly, B., Ocegueda, I., Peralta, H., Garcia, B. A., et al. (2022) · Biochemistry · doi:10.1021/acs.biochem.2c00363 · Cited by 9 · see citing works

Techniques in Protein Methylation

Lee, J. H., Cheng, D., & Bedford, M. T. (2004) · Humana Press eBooks · doi:10.1385/1-59259-816-1:195 · Cited by 21 · see citing works

A new type of protein methylation activated by tyrphostin A25 and vanadate

Miranda, T. B., Lowenson, J. D., & Clarke, S. G. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.080 · Cited by 10 · see citing works

Protein L-isoaspartyl methyltransferase regulates p53 activity

Lee, J., Kang, S.-U., Jeon, Y., Park, J. W., You, J.-S., Ha, S.-W., Bae, N., Lübec, G., Kwon, S. H., Lee, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1933 · Cited by 64 · see citing works

Unusual Sites of Arginine Methylation in Poly(A)-binding Protein II and in Vitro Methylation by Protein Arginine Methyltransferases PRMT1 and PRMT3

Smith, J. J., Rücknagel, K. P., Schierhorn, A., Tang, J., Németh, A., Linder, M., Herschman, H. R., & Wahle, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13229 · Cited by 146 · see citing works